← Back
$NMRA All transactions

Neumora Therapeutics, Inc.

D

$ Value

Shares

38,234

Price

Filed

May 30

Insider

Name

Milligan Michael Lee

Title

See Remarks

CIK

0001993953

Roles

Officer

Transaction Details

Transaction Date

2025-05-28

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. | On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. | 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. | 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. | 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. | 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. | On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

Filing Info

Accession No.

0000950170-25-079926

Form Type

4

Issuer CIK

0001885522

Milligan Michael Lee's History

Date Ticker Type Value
2026-01-08 NMRA A $0
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA A
2025-05-28 NMRA A
2025-05-28 NMRA A
2025-05-28 NMRA A

Other Insiders at NMRA (90d)

No other insider activity at this issuer in the last 90 days.